Daiichi Sankyo

Daiichi Sankyo Company, Limited is a Japanese pharmaceutical company specializing in the research, development, and manufacture of prescription medicines. It operates globally, focusing on oncology, cardiovascular, and other therapeutic areas. The company sells its products primarily in Japan, the United States, and other international markets.

Why investors watch it

Daiichi Sankyo is a key player in Japan's pharmaceutical sector and is closely watched by foreign investors for its innovation pipeline and global expansion efforts. The stock is sensitive to changes in healthcare policy and regulatory environments in both Japan and overseas markets. Its position in oncology and cardiovascular treatments gives it relevance amid growing global demand for specialty medicines.